Prophylactic use of ofloxacin in granulocytopenic patients with hematological malignancies during post-remission chemotherapy.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Internal medicine

• Publication date

  1992-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.31.319PMID 1611181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.

  2020cited by this paper
• Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.

  1990cited by this paper
• [Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].

  1990cited by this paper
• Review on internal medicine(1988). Recent progress in treatment of haematological malignancies. I. Drugs. 1) Anti cancer agents.

  1989cited by this paper
• Prophylaxis of infection in bone marrow transplants.

  1988cited by this paper
• Acute myelogenous leukemia: recent advances in therapy.

  1987cited by this paper
• Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

  1987cited by this paper
• Pharmacokinetics of ofloxacin after parenteral and oral administration

  1987cited by this paper
• Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.

  1986cited by this paper
• The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.

  1985cited by this paper
• The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

  1985cited by this paper
• Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies.

  1983cited by this paper
• Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

  1983cited by this paper
• Final Results of Cooperative Study of VEPA [Vincristine, Cyclophosphamide (Endoxan), Prednisolone and Adriamycin] Therapy in Advanced Adult Non-Hodgkin's Lymphoma: Relation Between T- or B-Cell Phenotype and Response

  1982cited by this paper
• Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression.

  1980cited by this paper
• Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.

  1975cited by this paper
• Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

  1972cited by this paper

• Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.

  2018cites this paper
• Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

  2012cites this paper
• Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients

  2007cites this paper
• Antibiotic prophylaxis in neutropenic patients

  2006cites this paper
• Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.

  2006influential citation
• Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients

  2005cites this paper
• Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

  2005cites this paper